Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Investigation of endoplasmic reticulum calcium signaling in striatal neurons of the YAC128 Huntington’s disease mouse model

FY 2021-22

Summary
Huntingtons disease (HD) is a neurodegenerative disorder characterized by loss of motor control, involuntary movement and cognitive deficits. HD results from a mutation on the Huntingtin gene (HTT) and involves disrupted signaling within the striatum, a brain region important for motor learning. While there is currently no cure for HD, some studies have identified Ca2+ signaling as a potential target for therapeutic intervention, as neurons depend on controlled Ca2+ homeostasis to regulate synaptic transmission. In particular, Ca2+ signaling is disrupted in HD at the level of the endoplasmic reticulum (ER) membrane, an important region for regulating Ca2+ homeostasis. The proposed study aims to investigate two specific mechanisms involved in regulating ER Ca2+ signalling in the context of HD. Aim 1: To evaluate the effects of type 1 inositol (1,4,5)-triphosphate glutamate receptor (IP3R1), a Ca2+ ion channel within the ER membrane, on cytoplasm-to-nucleus Ca2+ signaling. Since IP3R1 shows increased sensitivity in HD, we hypothesize that downregulating IP3R1 will normalize Ca2+ signaling in corticostriatal cultures from the YAC128 mouse model of HD. In addition, the ER-localized Sigma-1 receptor (S1R) is also involved in regulating Ca2+ signaling and the ER stress response. Aim 2: To evaluate the effects of an S1R agonist on cytoplasm-to-nucleus Ca2+ signaling. We hypothesize that adding an S1R agonist to YAC128 corticostriatal cultures will restore ER Ca2+ signaling to control levels. By examining ER Ca2+ signaling in YAC128 striatal neurons under different conditions, the proposed project will enable a better comprehension of disrupted Ca+ homeostasis in HD and provide insight into the development of potential therapeutics for early intervention of HD.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466585
Name
Cheng Judy (Li-Hsuan)
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigation of endoplasmic reticulum calcium signaling in striatal neurons of the YAC128 Huntington’s disease mouse model
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Activin A; Calcium Signalling; Endoplasmic Reticulum; Huntington'S Disease; Ip3 Receptor; Mouse Model; Nmda Receptor; Striatum
Abstract
Huntingtons disease (HD) is a neurodegenerative disorder characterized by loss of motor control, involuntary movement and cognitive deficits. HD results from a mutation on the Huntingtin gene (HTT) and involves disrupted signaling within the striatum, a brain region important for motor learning. While there is currently no cure for HD, some studies have identified Ca2+ signaling as a potential target for therapeutic intervention, as neurons depend on controlled Ca2+ homeostasis to regulate synaptic transmission. In particular, Ca2+ signaling is disrupted in HD at the level of the endoplasmic reticulum (ER) membrane, an important region for regulating Ca2+ homeostasis. The proposed study aims to investigate two specific mechanisms involved in regulating ER Ca2+ signalling in the context of HD. Aim 1: To evaluate the effects of type 1 inositol (1,4,5)-triphosphate glutamate receptor (IP3R1), a Ca2+ ion channel within the ER membrane, on cytoplasm-to-nucleus Ca2+ signaling. Since IP3R1 shows increased sensitivity in HD, we hypothesize that downregulating IP3R1 will normalize Ca2+ signaling in corticostriatal cultures from the YAC128 mouse model of HD. In addition, the ER-localized Sigma-1 receptor (S1R) is also involved in regulating Ca2+ signaling and the ER stress response. Aim 2: To evaluate the effects of an S1R agonist on cytoplasm-to-nucleus Ca2+ signaling. We hypothesize that adding an S1R agonist to YAC128 corticostriatal cultures will restore ER Ca2+ signaling to control levels. By examining ER Ca2+ signaling in YAC128 striatal neurons under different conditions, the proposed project will enable a better comprehension of disrupted Ca+ homeostasis in HD and provide insight into the development of potential therapeutics for early intervention of HD.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cheng, Judy (Li-Hsuan)
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~